BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM TOX

File: 123096_sep96_decls58_0005.txt
Page: 0005
Total Pages: 9

Subject: BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM TOX    

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM                                               

Document Number:          1

Folder Seq  #:        226



                                       UNCLASSIFIED
                                     .IlQr.12p" m
                                      1%)LUIIL- I


             e. (U) It is critical that chain of custody be maintained from
         patient to the laboratories and within the laboratories. It is the
         responsibility of the intelligence community with the operations
         cell to ensure that chain of custody is maintained and that
         expeditious shipment of samples is accomplished. Command emphasis
         and support is required. CINCCENT visibility is required to
         expedite shipment of samples. Dedicated aircraft for CONUS sample
         shipment if highly recommended. The British have dedicated
         aircrafts for their sample shipment to UK. Samples are perishable,
         and timely confirmation of BW attack is critical.

         5. @ If the BW Warning and Detection System fails to detect BW
         attack(s), the first warning will be the sick SM.

             a. (U) The medical system will be vigilant for these patients
         and will immediately report suspected BW patients to the medical
         intelligence and operations channel.

             b. (U) The S-2/G-2 and S-3/G-3 with assistance from medical
         should pin-point the location of the units from which the patients
         came from.

             c. @    If these patients were anthrax positive, antibiotic
         treatment should beain immediately for those units. At the same

         Vigilance will be maintained for other anthrax positive cases.





             e. (U) Biomedical samples from patients will be immediately
         shipped to the Navy Forward Lab (AOR), Army Lab (AOR), and/or 10th
         Medical Laboratory (USAREUR). In addition, samples will be
         submitted to U.S. Army Medical Research Institute of Infectious
         Disease (USAMRIID) at Fort Detrick, Frederick, MD. Biomedical
         samples will be refrigerated and receive priority shipment. They
received by USAMRIID within 48 hrs. Guidelines for taking
         of samples and documentation of information is provided in
         reference (CRDEC publication). Location of labs is in reference
         message. Note these laboratories are capable of handling
         biomedical samples, not environmental samples.

             f. @ It is critical that chain of custody be maintained from
         patient to the laboratories and within the laboratories. It is the
         responsibility of the intelligence community with the operations
         cell to ensure that chain of custody is maintained and that
         expeditious shipment of samples is accomplished. Command emphasis



                                           2


                                       UNCLASSIFIED
                                       JIZCPDE:L
                                           Ul

Document 9 f:/Week-36/BX003203/BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM/biological warfare defense against anthrax and b:12179609290159
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM
Folder Seq # = 226
Subject = BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND B
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996